Publication Beamlines Strategic Pillar
(2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2024). Antibodies that bind to a complex containing TNF from the TNF superfamily and a small molecule that is its modulator. Patent Number: IL256099B2.
(2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0.
(2023). Antibodies to tigit. Patent Number: IL298111A.
(2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2.
(2023). teclistamab. Patent Number: NL301219I2.
(2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1.
(2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T.
(2023). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL257468B2.
(2022). ANTIBODY EPITOPE. Patent Number: PT3311171T.
(2023). Novel tnf structure for use in therapy. Patent Number: PT3311168T.
제임스 필립 오코넬; 존 로버트 포터; 알라스테어 로손; 다니엘 존 라이트우드; 레베카 제인 우튼 et al. (2023). antibody. Patent Number: KR102599907B1.
켈시 시빅 고티에; 니겔 펠험 클린턴 워커; 샤오닝 자오; 존 리핀코트 (2023). Antibodies to TIGIT. Patent Number: KR20230019152A.
한 리; 도로씨아 코미노스; 지에 장; 알라 프리츠커; 매튜 데이비슨 et al. (2022). Antibodies to bradykinin b1 receptor ligands. Patent Number: KR20220031728A.